NYU Langone


 

ASCO GI 2023 Preliminary Efficacy and Correlative Results of the Phase II Trial HCRN GI16-288: Perioperative CV301 Vaccination in Combination With Nivo and Systemic Chemo for Resectable Hepatic-Limited mCRC

83 views
February 23, 2023
0 Comments
Login to view comments. Click here to Login
Videos